Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06051-w ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Mingyang Gao und 19 weiteren Autor:innen. Beteiligte Einrichtung: Medical Center of Hematology, State Key Laboratory of Trauma and Chemical Poisoning, Xinqiao Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Anemia, Aplastic, Hematopoietic Stem Cell Transplantation, Siblings, HLA Antigens. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Training Plan for Clinical Medical Scientific Research Talents of Army Medical University, Chongqing Science and Health Joint Medical Scientific Research Project.
Abstract (Originalsprache)
In recent years, great progress has been made in haploidentical hematopoietic stem cell transplantation (haplo-HSCT) treatment for hematological malignant diseases because of the advent of novel conditioning regimens, optimized graft manipulation, improved graft-versus-host disease (GVHD) prophylaxis, and advances in supportive care. Recent studies have shown very favorable outcomes in severe aplastic anemia (SAA) patients, with comparable outcomes to those of patients receiving immune suppressive therapy (IST) and allogeneic HSCT from a matched sibling donor (MSD) or matched unrelated donor (MUD). However, most of the previous studies relied on single-center data analyses, and the conditioning regimen, GVHD prophylaxis and supportive care used were relatively singular. We do not know whether there are differences in the survival of SAA patients after haplo-HSCT and MSD-HSCT under conditions involving different transplant centers, conditioning regimens and GVHD prophylaxis. This is a disease-specific, multicenter and retrospective study. We retrospectively studied 156 consecutive patients with SAA who underwent haplo-HSCT or MSD-HSCT at four transplant centers in China. The 5-year overall survival (OS) rate was 87.5% in the haplo-HSCT group and 89.7% in the MSD-HSCT group. The time to hematopoietic reconstitution, incidence of graft versus host disease, and infection and graft failure rates were not significantly different between the groups. Haplo-HSCT achieved outcomes comparable to those of MSD-HSCT for SAA patients. According to the nomogram score, we developed a SAA prognostic scoring system. Haplo-HSCT should be considered an effective alternative for patients with SAA without a matched sibling donor. The SAA transplant-specific prognostic scoring system proposed in this study can conveniently predict the OS for SAA patients following MSD-HSCT or haplo-HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Center of Hematology, State Key Laboratory of Trauma and Chemical Poisoning, Xinqiao Hospital, Army Medical University, Chongqing, China.
- Department of Hematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, China.
- Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, P. R. China.
- Department of Hematology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Health Statistics, College of Military Preventive Medicine, Army Medical University, Chongqing, China.
- Medical Center of Hematology, State Key Laboratory of Trauma and Chemical Poisoning, Xinqiao Hospital, Army Medical University, Chongqing, China. zhangxxi@sina.com.
Förderung
- National Natural Science Foundation of China
- Training Plan for Clinical Medical Scientific Research Talents of Army Medical University
- Chongqing Science and Health Joint Medical Scientific Research Project
Zitieren
APA
Gao, M., Huang, X., Gao, S., Wang, S., Deng, J., Zhang, Y., Kong, P., Zhang, C., Gao, L., Feng, Y., Zhu, L., Liu, J., Chen, T., Yao, H., Wang, L., Liu, H., Liu, Y., Zhao, L., Zhang, X., & Gao, L. (2024). Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system. Annals of Hematology. https://doi.org/10.1007/s00277-024-06051-w
Vancouver
Gao M, Huang X, Gao S, Wang S, Deng J, Zhang Y, et al. Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system. Annals of Hematology. 2024. doi:10.1007/s00277-024-06051-w
BibTeX
@article{Gao2024,
author = {Gao, Mingyang and Huang, Xiaobing and Gao, Shichun and Wang, Sanbin and Deng, Jianchuan and Zhang, Yanqi and Kong, Peiyan and Zhang, Cheng and Gao, Li and Feng, Yimei and Zhu, Lidan and Liu, Jia and Chen, Ting and Yao, Han and Wang, Lu and Liu, Huanfeng and Liu, Yuqing and Zhao, Lu and Zhang, Xi and Gao, Lei},
title = {Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06051-w}
}
EUVIMED